Medtronic (NYSE:MDT) announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable ...

Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...

Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.

Abbott recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 CGM systems.

The MiniMed 780G automated insulin delivery system with the Simplera Sync CGM. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose ...

Tidepool announced today that it secured a new certification for its open-source quality management system, known as qmsOS. Palo Alto, California-based Tidepool, a non-profit diabetes data management ...